Issue: January 2018
November 29, 2017
4 min read
Save

Increased levels of any physical activity reduce mortality, CVD risk

Issue: January 2018
Salim Yusuf, MBBS, DPhil
Salim Yusuf

Higher levels of recreational and nonrecreational physical activity reduced the risk for CVD events and mortality in participants from low-, middle- and high-income countries, according to new data from the PURE study published in The Lancet.

Perspective from Monica Aggarwal, MD, FACC

“For low- and middle-income countries where having heart disease can cause a severe financial burden, physical activity represents a low-cost approach that can be done throughout the world with potential large impact,” Salim Yusuf, MD, DPhil, MRCP, professor in the department of medicine, joint member of the department of health research methods, evidence and impact and director of the Population Health Research Institute at McMaster University in Ontario, Canada, and principal investigator of the PURE study, said in a press release.

PURE study data

Scott A. Lear, PhD, professor at Simon Fraser University Faculty of Health Sciences in British Columbia, Canada, and Pfizer/Heart and Stroke Foundation Chair in Cardiovascular Prevention Research, and colleagues reviewed data from 130,843 participants aged 35 to 70 years (mean age, 50 years; 42% men) from in the PURE study who were free from CVD.

Standardized procedures and measures were used to record data, including medical history, sociodemographic factors, risk factors and lifestyle behaviors. The International Physical Activity Questionnaire was used to assess physical activity.

Low physical activity was defined as less than 150 minutes of moderate-intensity physical activity, moderate physical activity was between 150 and 750 minutes per week and high physical activity was identified as more than 750 minutes per week.

Participants were also categorized by country income level: high, upper middle, lower middle and low.

The primary clinical outcomes were a composite or individual incidence of mortality and major CVD, which included CVD mortality and stroke, MI or HF. Patients were followed up for a mean of 6.9 years.

The risk for all-cause mortality was reduced with moderate (HR = 0.8; 95% CI, 0.74-0.87) and high physical activity (HR = 0.65; 95% CI, 0.6-0.71) compared with low physical activity. Moderate physical activity was also related to a risk reduction for major CVD vs. low physical activity (HR = 0.86; 95% CI, 0.78-0.93).

Reduced risk for CVD, mortality

A significantly lower risk for mortality and major CVD was seen in participants from upper middle- and low-income countries who had higher physical activity. The risk for mortality decreased in upper middle-, lower middle- and low-income countries with higher physical activity. Upper middle- and low-income countries had a decrease in major CVD risk in participants with higher physical activity.

PAGE BREAK

At 5 years, the adjusted population attributable fraction for participants who did not meet physical activity guidelines was 4.6% for major CVD and 8% for mortality, and the adjusted population attributable fraction for participants who did not achieve high physical activity was 9.5% for major CVD and 13% for mortality.

Higher rates of both recreational and nonrecreational physical activity reduced risk that was equivalent to 150 minutes per week of moderate-intensity physical activity (P = .01) and 1,250 minutes per week (P < .0001), respectively.

“The affordability of other CVD interventions such as consuming fruits and vegetables and generic CVD drugs is beyond the reach of many people in low-income and middle-income countries; however, physical, activity represents a low-cost approach to CVD prevention,” Lear and colleagues wrote.

“Creating a physical, social and political environment where physical activity in daily living is desirable, accessible and safe should be a developmental imperative; a planning, economic, social and equity imperative; and a public health imperative,” Shifalika Goenka, MBBS, PhD, of the Public Health Foundation of India and Center for Chronic Disease Control in New Delhi, and I-Min Lee, professor in the department of epidemiology at Harvard T. H. Chan School of Public Health, wrote in a related editorial. “Parallel to pedestrian pavements, we need additional active transport roads for the many different modes of active transport along with cycling.” – by Darlene Dobkowski

Disclosures: The PURE study was funded by AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, King Pharma, Novartis, Sanofi Aventis and Servier. Lear, Yusuf, Goenka and Lee report no relevant financial disclosures.